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Abstract The objective of the current study was to determine the effect of ractopamine supple-
mentation on gut populations and fecal shedding of Salmonella in growing pigs. Sixteen cross-
bred pigs (avg. BW = 33 kg) were fed a grower ration with and without ractopamine (18 g/ton
feed) for 38 days. Four days prior to termination of the study, all pigs were experimentally infected
with Salmonella Typhimurium. Fecal samples were collected daily for quantification of the chal-
lenge strain and four days following inoculation, all pigs were euthanized and necropsied. Fecal
shedding of Salmonella was decreased (P < 0.05) in pigs fed ractopamine. The number of
Salmonella-positive tissue samples from the liver was decreased (P = 0.05) and the number of
positive ileo-cecal lymph nodes tended (P = 0.13) to decrease in the ractopamine treatment.
Results of this preliminary study indicate ractopamine may have the added benefit of reducing
Salmonella populations in growing pigs. 
Introduction Foodborne Salmonella infections in the United States are estimated to cost approxi-
mately $2.3 billion annually with 6-9% of the human cases of salmonellosis linked to the con-
sumption of pork or pork products (Frenzen et al, 1999). Salmonella has been isolated throughout
all stages of the pork production cycle and has received considerable attention, not only from a
food safety standpoint, but additionally, because Salmonella can cause clinical infection in swine.
Two general factors are attributed to Salmonella infection in pigs: inputs (pigs, feed, rodents, etc.)
and activities within the swine production process (animal mixing, transport, misc. management
factors). While modern pork production systems effectively keep stress to a minimum, it is still an
inherent part of the process and may include: transport, handling, co-mingling, breakdown of
social groupings, food deprivation, temperature fluctuations, and noise.  
Stress is known to affect the immune system (Khansari et al, 1990) and is generally believed
to increase the number of pigs shedding Salmonella and/or increase their susceptibility to
Salmonella infections. Physiological responses to stress involve a neuroendocrine response facili-
tating adaptation to the external environment that is partly regulated by the hypothalamic-pitu-
itary-adrenocortical axis, resulting in increased levels of glucocorticoids and catecholamines. The
catecholamines (epinephrine and norepinephrine), in addition to having effects on gut motility and
smooth muscle contraction, have been shown to stimulate growth of E. coli (Burton et al, 2002)
and Salmonella (Rahman et al, 2000) in vitro. Interestingly, the catecholamine hormones have
been reported to be involved in a bacterial quorum-sensing system that regulates virulence gene
expression of E. coli O157:H7 (Sperandio et al, 2003), stimulates the growth of intestinal com-
mensal E. coli and E. coli O157:H7 (Lyte et al, 1996; 1997) and augments the intestinal inflamma-
tory, secretory responses, and adherence to intestinal mucosa of this pathogen (Vlisidou et al,
2004). We hypothesize that norepinephrine, present throughout the small intestine, may have a
similar effect on other gram-negative bacteria such as Salmonella.
Ractopamine hydrochloride is a synthetic b-agonist that repartitions nutrients to increase lean
vs adipose disposition (Ricks et al, 1984; Moody et al, 2000) and improves performance, carcass
leanness and dressing percent in finishing pigs (Anderson et al, 1987; Watkins et al, 1990).
Interestingly, b-agonists chemically and pharmacologically resemble the hormones norepinephrine
and epinephrine (Bell et al, 1998; Mersmann 1998).  The administration of b-agonists to pigs ele-
vated plasma norepinephrine (Mersmann 1989), although in a similar cattle experiment, plasma
epinephrine and norepinephrine were unchanged (Blum and Flueckiger, 1988). Recently, rac-
topamine was approved by the United States Food and Drug Administration for use in finishing
beef cattle to be fed the last 28 days of the finishing period for similar performance and carcass
improvements. We hypothesized that feeding the b-agonist ractopamine would either directly, or
via elevated plasma norepinephrine, increase GIT populations and/or fecal shedding of E. coli
O157:H7 in feedlot cattle. Interestingly however, we saw just the opposite effect, with a decrease
in fecal shedding observed in ractopamine supplemented cattle (Edrington et al, 2005). This led to
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the objective of the current research: to determine the effect of ractopamine supplementation on
gut populations and fecal shedding of Salmonella, an important gram negative bacterial pathogen,
in swine.    
Materials and Methods Sixteen crossbred pigs (barrows and gilts; avg. BW = 33 kg) were pur-
chased from the Texas Department of Criminal Justice and transported to our facilities at the Food
and Feed Safety Research Unit in College Station, TX. Immediately upon arrival, piglets were
weighed, ear-tagged, and randomly assigned to pens (8 pigs/pen) and treatment (sex equally dis-
tributed across treatments): Control (pig grower only) or Ractopamine (pig grower containing
Paylean® 9, to provide 18 g ractopamine/ton feed). Feed and water were provided for ad libitum
consumption throughout the experimental period. Fourteen days after initiation of treatments,
pigs were individually penned and fed their respective diets for an additional 24 days (38 total
days on experimental diets). Two days following individual penning, fecal samples were collected
from all pigs and plated on brilliant green agar containing novobiocin and naladixic acid (25 and 20
µg/mL, respectively; BGANN) to screen for the presence of antibiotic resistant wild-type
Salmonella prior to experimental infection. On day 34, all pigs were experimentally infected with 5
mL of tryptic soy broth containing 4.5 x 107 CFU of a novobiocin and naladixic acid resistant
Salmonella Typhimurium via oral gavage. Individual fecal samples were collected daily for quantifi-
cation of the challenge strain as described below. Four days post-infection, all pigs were humanely
euthanized and tissue and luminal contents collected from the ileum, cecum, colon and rectum.
Tissue samples were also collected from the ileocecal lymph nodes, spleen, and liver for qualifica-
tion of Salmonella. Body weights were recorded at the beginning and end of the study. 
Salmonella Culture Fecal samples and luminal contents (1 g) were serially diluted, plated on
BGANN agar and incubated overnight (24 h, 37°C). Tissue samples were enriched in tetrathionate
broth (24 h, 37°C) before plating on BGANN for qualitative determination of the challenge strain.
Statistical Analyses Daily fecal shedding data were analyzed as repeated measures using the
MIXED procedure of SAS (SAS Inst. Inc., Cary, NC). Chi-square analysis using the FREQ procedure
of SAS, was used to determine influence of treatment on qualitative bacterial enumeration of tis-
sue samples. Salmonella populations in luminal contents and BW were subjected to analysis of
variance appropriate for a completely randomized design. Least square means were compared
using Duncan’s mean separation statement when significant (P<0.05) differences detected.  
Results Prior to challenge with the experimental Salmonella strain, all fecal samples were nega-
tive for wild-type Salmonella capable of growth on BGANN. Fecal shedding of the challenge strain
of Salmonella is presented by day (Figure 1), even though a treatment by day interaction was not
observed (P>0.20). Salmonella shedding was higher in the control animals each day post-chal-
lenge, decreasing over time (P<0.01),
with low levels of shedding detected only
in control animals by the end of the
experimental period. When examined
across days, pigs fed ractopamine shed
less (P<0.01) Salmonella than control ani-
mals over this four day period (Table 1).
Populations of Salmonella in the luminal
contents of the ileum, cecum and rectum
were not different (P>0.20) due to treat-
ment, while counts in the colon contents
were one log lower in the ractopamine
treatment (P=0.18). The number of
Salmonella-positive tissue samples from
the liver was decreased (P=0.05) and the
number of positive ileo-cecal lymph
nodes tended (P=0.13) to decrease in the
ractopamine treatment (Table 1). Body
weights were similar among treatments
prior to initiation of experimental diets.
Pigs fed ractopamine tended (P=0.13) to gain weight over
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Figure 1. Fecal shedding (CFU/g feces log10)
of the challenge strain of Salmonella in feeder
pigs fed diets with and without ractopamine.
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the 38 day feeding period (Table 1). Feed intakes were similar among treatments (data not
shown).
Discussion Results of the current research indicate that ractopamine supplementation to growing
pigs may influence gut populations and fecal shedding of Salmonella Typhimurium and indicate
further research is warranted. We hypothesized that ractopamine would produce responses in
gram-negative bacteria similar to those reported for the catecholamines (Burton et al, 2002
Rahman et al, 2000) and increase Salmonella populations. Interestingly, all of the affects observed
in the ractopamine treatment, although slight involved a reduction, not an increase as we expect-
ed, in Salmonella. Reasons for this are unknown but may involve changes in hormone concentra-
tions, gut turnover, effect on smooth muscle contraction, or other unknown mechanisms.  
Previously, we fed ractopamine to feedlot cattle naturally-infected with E. coli O157:H7 and
saw a decrease in the number of ractopamine supplemented cattle shedding this pathogen
(Edrington et al, 2005). Plasma catecholamines were not different among treatment groups and
did not provide any explanation for the observed results. Due to the results in the cattle study
coupled with the difficulty in handling and restraining pigs and the stress involved, we did not col-
lect blood samples for catecholamine analysis in this preliminary study with swine. Future studies
utilizing less stressful catheterization procedures may be employed to examine catecholamine
concentrations while limiting as much as possible, the stress associated with blood collection.
While the effects observed in the current study are modest, increasing the numbers of animals
used and thereby the sensitivity and ability to detect differences, may yield more substantial
effects of ractopamine supplementation on pathogen populations.   
Conclusions The effects of ractopamine on performance and carcass characteristics in finishing
swine are well documented.  The present work has exciting implications considering this com-
pound, designed to be fed immediately prior to slaughter, may have the added benefit of reducing
foodborne pathogens.  Future work will examine the effects of ractopamine feeding in market
hogs naturally colonized with Salmonella.
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Treatment: Control Ractopamine SEMa P-value
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(CFU/g log10), Salmonella positive tissue samples, and BW change in feeder pigs
experimentally infected with Salmonella and fed a grower ration with and with-
out ractopamine. aStandard error of the mean. bNo treatment by day interaction
(P>0.20), therefore data were pooled and averaged across days. cIleo-cecal
lymph nodes. deValues within row without a common superscript differ (P<0.05).
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